Status:
COMPLETED
Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)
Lead Sponsor:
Boston Children's Hospital
Conditions:
Biomedical Technology
Type 1 Diabetes
Eligibility:
All Genders
5-25 years
Brief Summary
Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.
Detailed Description
Outcome study of 90-100 patients with type 1 diabetes who elected to use the Medtronic 670G. Major outcome measure was to assess the percent of patients who were able to successfully continue to use ...
Eligibility Criteria
Inclusion
- clinical diagnosis of T1D
- patient of Boston Childrens Hospital diabetes program
- deemed to be adequate candidates for hybrid closed loop technology by their diabetes health care team
- patient received Medtronic 670G training at Boston Childrens Hospital
- patient received follow up diabetes care at Boston Childrens Hospital for at least 3 months after starting on the 670G
Exclusion
- patients not trained at Boston Childrens Hospital or self started
Key Trial Info
Start Date :
June 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2019
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04051632
Start Date
June 13 2018
End Date
July 30 2019
Last Update
August 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Childrens Hospital
Boston, Massachusetts, United States, 02115